FDA Shares Draft Guidelines for Testing Tampons Pads and Cups
Published Date: 11/17/2025
Notice
Summary
The FDA just dropped draft guidance to help makers of tampons, pads, and menstrual cups test and label their products better. This means clearer info and more consistent quality checks for these everyday essentials. Companies should check it out and send their feedback by January 16, 2026, before the rules get finalized—no costs or changes are official yet!
Analyzed Economic Effects
5 provisions identified: 5 benefits, 0 costs, 0 mixed.
Tampon Testing for TSS and Microflora
The draft guidance includes recommended test methods for evaluating tampons for Toxic Shock Syndrome (TSS) risk and effects on vaginal microflora, and clarifies non-clinical bench testing methods for tampons. These are recommendations in a draft FDA document with a comment deadline of January 16, 2026.
Ingredient Disclosure on Outer Labels
The FDA draft guidance recommends that manufacturers disclose ingredients, including fragrances and deodorants, on all menstrual product outer package labels. This is guidance (not final), and the Agency asked for comments by January 16, 2026.
Evaluation of Contaminants for Menstrual Products
The draft guidance recommends evaluating contaminants for all menstrual products (tampons, pads, and menstrual cups) as part of performance testing. The recommendations are for industry and are not final; FDA sought comments by January 16, 2026.
Menstrual Cups Included in Guidance
The draft guidance expands the scope of recommendations to include menstrual cups, in addition to tampons and pads, for performance testing and labeling. The draft is not final and FDA requested comments by January 16, 2026.
Support for Non-Animal Testing Options
FDA states it supports the '3Rs' (replace, reduce, refine animal use) and encourages manufacturers to consult FDA if they want to use non-animal testing methods; FDA will consider whether proposed alternative methods are equivalent. This is guidance (not final) and comments were requested by January 16, 2026.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11966 — Forms FDA 3542a and FDA 3542: Questions and Answers; Draft Guidance for Industry; Availability
The FDA just dropped a draft guide to help businesses fill out Forms FDA 3542a and FDA 3542 without confusion. If you submit these forms, this guide answers your top questions and makes the process smoother. You’ve got until August 14, 2026, to send in your feedback before the FDA finalizes the guide—no extra costs, just clearer steps!
2026-11998 — Amendment and Revocation of Organizational Information Regulations
The FDA is updating its rules to point everyone to its website for the latest contact and organizational info, ditching old, unnecessary regulations. This makes it easier for the public to find accurate info all in one place, starting June 15, 2026. If you interact with the FDA, expect smoother access with no extra costs or delays.
2026-11760 — Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Establishment, Maintenance, and Availability of Records; Additional Traceability Records for Certain Foods
The FDA is asking for approval to collect extra records from food businesses that handle certain high-risk foods. This helps track food sources quickly to keep everyone safe. Food companies should get ready to keep and share these new records, and comments on this plan are due by July 13, 2026.
2026-11762 — Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Procedures for the Safe Processing and Importing of Fish and Fishery Products
The FDA is asking for approval to keep collecting info from seafood processors and importers to make sure fish products are safe using a system called HACCP. This affects anyone who processes or imports fish and requires them to keep records showing they’re following safety rules. Comments on this plan are open until July 13, 2026, and there’s no new cost, just a continuation of current paperwork.
2026-11739 — Medical Devices; Immunology and Microbiology Devices; Classification of the Simple Point-of-Care Device to Directly Detect SARS-CoV-2 Viral Targets From Clinical Specimens in Near-Patient Settings
The FDA is officially putting simple COVID-19 rapid test devices into a safer, easier-to-manage category called Class II. This change means these tests can get to patients faster and with fewer hoops to jump through, while still making sure they work well and stay safe. Starting June 11, 2026, companies making these tests will follow new rules that help speed up innovation without extra costs.
2026-11740 — Medical Devices; Immunology and Microbiology Devices; Classification of the Spinal Muscular Atrophy Newborn Screening Test System
The FDA is officially putting the Spinal Muscular Atrophy (SMA) newborn screening test into class II, meaning it has special safety rules but fewer hurdles than the strictest category. This change helps make the test safer and easier to get to babies who need it, starting June 11, 2026, with the classification effective since November 2022. Labs and device makers will benefit from clearer rules and faster access, helping catch SMA early without extra costs or delays.
Previous / Next Documents
Previous: 2025-19947 — Quality Management System Information for Certain Premarket Submission Reviews; Draft Guidance for Industry and Food and Drug Administration Staff; Availability
The FDA is sharing a draft guide to help medical device makers and staff understand new rules about Quality Management Systems starting February 2, 2026. These changes align U.S. rules with global standards, making it easier to prepare and share quality info in device marketing submissions. If you’re in the medical device world, get ready to update your paperwork and share your thoughts by January 16, 2026!
Next: 2025-19949 — Combined Notice of Filings #1
The Federal Energy Regulatory Commission got a bunch of electric companies asking to update their rates and status. This affects many wind, solar, and energy storage projects across the country, with possible changes in how much customers pay or when projects operate. If you want to speak up, you’ve got until November 24, 2025, at 5 p.m. ET to comment!